(Q28833693)
Statements
Ceramide-CD300f binding suppresses experimental colitis by inhibiting ATP-mediated mast cell activation (English)
0 references
May 2016
0 references
65
0 references
5
0 references
777-87
0 references
2 references
1 reference
1 reference
1 reference